C12N 2710/16334
Use of virus or viral component as vaccine
Official title: Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
C12N2710/16334 (Use of virus or viral component as vaccine) appears on 117 US grants and 97 published applications in this corpus.
Search patents in C12N- Granted patents
- 117
- Published applications
- 97
- Assignees
- 56
- Inventors
- 158
- Latest grant
- 6 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 3 | 0 |
| 1991 | 1 | 0 |
| 1992 | 3 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 3 | 0 |
| 1996 | 2 | 0 |
| 1997 | 3 | 0 |
| 1998 | 10 | 0 |
| 1999 | 7 | 0 |
| 2000 | 4 | 0 |
| 2001 | 6 | 1 |
| 2002 | 6 | 4 |
| 2003 | 1 | 3 |
| 2004 | 1 | 0 |
| 2005 | 0 | 5 |
| 2006 | 1 | 0 |
| 2007 | 1 | 2 |
| 2008 | 2 | 6 |
| 2009 | 3 | 1 |
| 2010 | 2 | 4 |
| 2011 | 1 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 3 |
| 2014 | 0 | 3 |
| 2015 | 5 | 5 |
| 2016 | 1 | 4 |
| 2017 | 3 | 4 |
| 2018 | 4 | 7 |
| 2019 | 7 | 9 |
| 2020 | 10 | 4 |
| 2021 | 1 | 8 |
| 2022 | 7 | 9 |
| 2023 | 3 | 3 |
| 2024 | 1 | 6 |
| 2025 | 9 | 4 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Recombinant non-pathogenic marek's disease virus constructs encoding infectious laryngotracheitis virus and infectious bursal disease virus antigens6 Jan 2026US 12,514,922 B2Intervet Inc.
- Recombinant viruses and the uses thereof9 Dec 2025US 12,491,242 B2Ceva Sante Animale
- Multivalent recombinant avian herpes viruses and vaccines for immunizing avian species14 Oct 2025US 12,440,555 B2Ceva Sante Animale
- Genetically modified cell line for production of Marek's disease virus vaccine and methods of making and using the same14 Oct 2025US 12,440,556 B2Zoetis Services LLC
- Serum-free medium for avian vaccine production and uses thereof14 Oct 2025US 12,441,989 B2Boehringer Ingelheim Vetmedica GmbH
- Cell line for production of marek's disease virus vaccine and methods of making and using the same2 Jul 2026US 2026/0183388 A1Zoetis Services LLC
- Recombinant Non-Pathogenic Marek's Disease Virus Constructs Encoding Infectious Laryngotracheitis Virus and Infectious Bursal Disease Virus Antigens22 Jan 2026US 2026/0021176 A1Intervet Inc.
- New multivalent hvt vector vaccine20 Nov 2025US 2025/0352642 A1Intervet Inc.
- Recombinant hvt vectors expressing multiple antigens of avian pathogens and uses thereof30 Oct 2025US 2025/0333766 A1Boehringer Ingelheim Animal Health USA Inc.
- Use of codon deoptimisation and optimisation to produce a laryngotracheitis virus-attenuated vaccine6 Mar 2025US 2025/0073331 A1Edge Animal Health, Inc.
Most cited
By later US patents
- Chicken interleukin-15 and uses thereof88US 6,737,522 B2Wayne State University · 2004
- Newcastle disease virus combination vaccine59US 5,733,556 AAkzo Nobel N. V. · 1998
- Method of treating birds35US 5,028,421 AEmbrex, Inc. · 1991
- Recombinant herpesvirus of turkeys comprising a foreign DNA inserted into a non-essential region of the herpesvirus of turkeys genome34US 6,121,043 ASyntro Corporation · 2000
- Recombinant herpesvirus of turkeys and uses thereof27US 5,853,733 ASyntro Corporation · 1998